Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Adial Pharmaceuticals, Inc. (ADIL) had Return on Tangible Equity of -35.05% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.96M |
|
-- |
|
-- |
|
$1.88M |
|
$-1.88M |
|
$-0.08M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.88M |
|
$-1.88M |
|
10.62M |
|
10.62M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$6.08M |
|
-- |
|
$0.72M |
|
$6.80M |
|
$1.21M |
|
-- |
|
-- |
|
$1.21M |
|
$5.59M |
|
$5.59M |
|
$5.59M |
|
21.54M |
|
| Cash Flow Statement Financials | |
$-3.33M |
|
$0.15M |
|
$5.35M |
|
$3.75M |
|
$5.92M |
|
$2.16M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-35.03% |
|
|
Return on Tangible Equity |
-35.05% |
-28.80% |
|
-35.03% |
|
$0.26 |
|
$-0.31 |
|
$-0.31 |
|